MeSH term
Frequency | Condition_Probility | Adult | 6 | 0.0 |
Comparative Study | 11 | 0.0 |
Humans | 55 | 0.0 |
Animals | 13 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Cytoplasm/immunology | 2 | 2.0 |
Dendritic Cells/immunology | 3 | 2.0 |
Disease Models, Animal | 2 | 0.0 |
Female | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 39 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Antigens, CD1/*immunology | 4 | 11.0 |
Cell Differentiation | 3 | 0.0 |
Cells, Cultured | 11 | 0.0 |
Dendritic Cells/cytology/*immunology | 2 | 3.0 |
Immunohistochemistry | 6 | 0.0 |
Aged | 3 | 0.0 |
Antigen Presentation | 3 | 0.0 |
Antigens, CD1/*immunology/metabolism | 2 | 40.0 |
Cell Line | 10 | 0.0 |
Male | 4 | 0.0 |
Middle Aged | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
*Antigen Presentation | 5 | 3.0 |
Lipids/*metabolism | 2 | 0.0 |
Antigen Presentation/*immunology | 2 | 2.0 |
Antigens, Bacterial/*immunology | 2 | 1.0 |
Hela Cells | 2 | 0.0 |
Mycobacterium tuberculosis/*immunology | 2 | 3.0 |
Antigens, CD1/*metabolism | 3 | 9.0 |
Biological Transport/immunology | 2 | 7.0 |
*Lectins, C-Type | 2 | 1.0 |
Antigens, CD/immunology | 3 | 0.0 |
Flow Cytometry | 8 | 0.0 |
HLA-DR Antigens/immunology | 2 | 0.0 |
Immunophenotyping | 8 | 0.0 |
Infant | 3 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Antigens, Bacterial/immunology | 2 | 1.0 |
*Lymphocyte Activation | 2 | 0.0 |
Antigens, Bacterial/chemistry/metabolism | 2 | 100.0 |
Mice | 8 | 0.0 |
Models, Molecular | 4 | 0.0 |
Protein Conformation | 2 | 0.0 |
T-Lymphocytes/immunology | 7 | 0.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Lymphocyte Activation | 6 | 0.0 |
Lymphocyte Culture Test, Mixed | 4 | 0.0 |
Tetanus Toxoid/immunology | 2 | 2.0 |
Amino Acid Sequence | 6 | 0.0 |
Antigens, CD1/*genetics | 2 | 14.0 |
Base Sequence | 6 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Dendritic Cells/*cytology | 2 | 3.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 2 | 0.0 |
Histocytochemistry | 2 | 0.0 |
Interleukin-4/pharmacology | 2 | 0.0 |
Phenotype | 6 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
Cell Differentiation/drug effects | 3 | 0.0 |
Solubility | 2 | 0.0 |
Antigens, CD/analysis | 4 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 2 | 1.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
Intercellular Adhesion Molecule-1/analysis | 2 | 1.0 |
Interleukin-4/*pharmacology | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
T-Lymphocyte Subsets/*immunology | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Child, Preschool | 3 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Antigens, CD1 | 10 | 10.0 |
Cloning, Molecular | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Transfection | 3 | 0.0 |
Gestational Age | 2 | 0.0 |
Antibodies/immunology | 2 | 0.0 |
Antigens, CD/*immunology | 3 | 0.0 |
Basement Membrane/immunology | 2 | 3.0 |
Langerhans Cells/immunology | 2 | 5.0 |
Dendritic Cells/*immunology | 2 | 0.0 |
B-Lymphocytes/*immunology | 3 | 0.0 |
Receptors, IgE | 2 | 3.0 |
Child | 2 | 0.0 |
T-Lymphocytes/*physiology | 2 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Antigens, Differentiation, B-Lymphocyte/*analysis | 3 | 5.0 |
Aged, 80 and over | 2 | 0.0 |
Thymus Gland/cytology/embryology/*immunology | 2 | 50.0 |
Lymphoma, Non-Hodgkin/*immunology | 2 | 9.0 |
Antibodies, Monoclonal/diagnostic use | 2 | 0.0 |
Killer Cells, Natural/immunology | 2 | 0.0 |